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SUMMARY Skin metastasis secondary to cancer of the prostate is rare 
and the prognosis is poor. A 65-year-old male patient diagnosed with 
metastatic colon carcinoma presented with polyuria and subcutaneous 
nodular mass on dorsal side of the corpus penis. The serum prostate 
specific antigen (PSA) level was 111.1 ng/mL and therefore the patient 
underwent transperineal prostate biopsy. Pathology reported adenocar-
cinoma of the prostate. The subcutaneous nodular lesion on the penis 
was totally excised and removed. Immunohistochemical examination 
of the excised mass was carcinoembryonic antigen (CEA) negative and 
PSA positive. Taking all these findings into consideration, the patient 
was diagnosed with prostate cancer that had metastasized to the penis. 
FOLFOX-4 chemotherapy regime in addition to bicalutamide and gos-
erelin acetate was administered to the patient who also had metastatic 
colon cancer. 
KeY woRdS: colorectal neoplasm, prostatic neoplasm, neoplasm me-
tastasis, penis, skin
INTRodUCTIoN
According to 2008 data in USA, when skin cancers 
are excluded, the prostate cancer prevalence is 25% 
of newly diagnosed cancer cases, and it is the most 
common cancer in men (1). Prostate cancer accounts 
of 10% of cancer related mortality; it is the second 
most common cancer after lung cancer (1). The most 
common sites of prostate carcinoma metastases are 
bone and lymph nodes. Skin metastases are very rare, 
presented in the literature with case reports. 
CASe HISToRY
A 65-year-old male patient was hospitalized for 
complaints of fatigue, weight loss and lower gastro-
intestinal bleeding. There was no other disease (e.g., 
diabetes mellitus, chronic heart or renal failure) in his 
medical history. A mass in the colon was detected 
with colonoscopy. The result of colonoscopic biopsy 
was reported as adenocarcinoma of the colon. One 
week later, the patient developed frequent urination 
again and a nodule on the dorsal part of the penile 
corpus while planning thorax and abdominal com-
puted tomography (CT) to detect the metastasis. 
The patient’s hematologic parameters, liver and renal 
function tests were in the normal range. Serum pros-
tate specific antigen (PSA) level was 111.1 ng/mL. A 
subcutaneous nodular lesion of 3x1.5 cm in diameter 
was detected on the dorsum of the penile corpus. 
Transperineal prostate biopsy was performed simul-
taneously with total excision of the penile mass. Pros-
tate biopsy report indicated perineural invasion-posi-
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tive adenocarcinoma of the prostate (Gleason’s score, 
8) (Fig. 1). Since immunohistochemical examination 
of the mass on the penile dorsum revealed carcino-
embryonic antigen (CEA)-negative (Fig. 2) and PSA-
positive (Fig. 3) staining, it was regarded as a metas-
tasis of adenocarcinoma of the prostate. In addition, 
in some areas tumoral microemboli were detected in 
vascular structures (Fig. 4). Multiple metastases were 
detected in the liver with abdominal CT. Bicalutamide 
50 mg/day plus goserelin acetate 3.6 mg/month in 
addition to 5-fluorouracil/leucovorin plus oxaliplatin 
(FOLFOX-4) chemotherapy regime was administered 
to the patient who had metastatic colon and prostate 
cancer. However, progression was observed in spite 
of therapy and the patient died 3 months later.
dISCUSSIoN
Skin metastases secondary to solid organ ma-
lignancies are rare. In a meta-analysis of seven large 
studies involving 20,380 patients, skin metastases 
were found in 5.3% of cases. The most frequent ma-
lignancy that causes skin metastases is breast cancer 
with an incidence of 24%, whereas prostate carcino-
ma is the one having the least percent of metastases 
with an incidence of 0.7% (2). Skin metastases origi-
nating from prostate carcinoma are usually found 
in the inguinal region and on the penis, but also in 
abdominal region, head and neck, chest, extremities 
and dorsal areas, in decreasing order of frequency (3). 
Clinically, skin lesions manifest as single or multiple 
nodules, edema, rash, priapism, painful erection and 
dysuria symptoms (3,4). In our patient, metastatic le-
sion was identified as a single, painless nodule on the 
dorsum of the penis. 
Metastases to the penis mainly originate from 
genitourinary system cancers (69%), followed by gas-
trointestinal system cancers (19%). Prostatic carcino-
ma is responsible for 25% of cases (4). Immunohisto-
chemical examination of skin metastases secondary 
to gastrointestinal system cancers shows CEA-posi-
tive staining, whereas metastases secondary to car-
cinoma of the prostate show PSA-positive staining 
(3-5). In our case, immunohistochemical examination 
indicated CEA-negative and PSA-positive staining. 
These findings supported our diagnosis of penile me-
tastasis secondary to carcinoma of the prostate. 
The probable mechanisms underlying skin metas-
tasis of prostate cancer are hematogenous spreading, 
lymphatic spreading and direct invasion (3,4). The 
presence of tumoral emboli in vascular structures in 
some areas of the pathological specimen obtained 
from the mass excised from the skin of the penis sug-
gested that this metastasis had followed the hema-
togenous pathway.
Figure 1. Perineural invasion positive prostatic adenocarci-
noma (HE; x400).
Figure 2. CEA-negative immunohistochemical staining of 
the penile mass (CEA; x200).
Figure 3. PSA-positive immunohistochemical staining of 
the penile mass (PSA; x400).
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No correlation between PSA level and penile me-
tastasis from prostate cancer has been reported in 
the literature to date. In most cases, PSA levels were 
elevated as in our patient (3,6-10). However, Kotake 
et al. and Kobashi-Katoh et al. report on patients that 
had not elevated PSA level at the time of penile me-
tastasis detection (4,11). However, these patients 
were taking hormonal therapy at that time. Therefore, 
PSA levels might not be elevated.
Prostate cancer with skin metastases have poor 
prognosis. The mean survival is 6-7 months (3,6). 
There is no standard treatment for these patients and 
individual treatment schemes need to be developed. 
Therapy should be chosen according to patient per-
formance and symptoms, site and number of meta-
static lesions. Treatment options are chemotherapy, 
hormonal therapy, radiotherapy, total excision of the 
lesion, and total or partial penectomy (3,6). Since 
our patient had a subcutaneous solitary nodule, we 
preferred total excision of the mass followed by hor-
monal therapy. 
Finally, it should be noted that penile metastases 
mainly originate from genitourinary system cancer, 
especially adenocarcinoma of the prostate. 
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Figure 4. Vascular invasion positive carcinoma metastasing 
to the penis (HE; x 100)
